期刊文献+

siRNA沉默胰腺癌Panc-1中THOC1对吉西他滨敏感性的影响 被引量:1

Effects of silencing THOC1 by si RNA on sensitivity of pancreas cancer cells Panc-1 to gemcitabine
下载PDF
导出
摘要 目的观察小干扰RNA(si RNA)沉默THOC1对胰腺癌Panc-1细胞吉西他滨敏感性的影响。方法将THOC1 si RNA通过瞬时转染于胰腺癌Panc-1细胞,使用q PCR和Western blot实验检验转染效果,通过MTT实验和平板克隆实验观察Panc-1细胞对吉西他滨敏感性的变化,并且通过Hoechst 33258染料核染色后观察Panc-1细胞在吉西他滨作用下凋亡反应的差异。结果成功转染THOC1 si RNA并有效抑制了THOC1的表达。转染THOC1 si RNA后Panc-1细胞对吉西他滨的药物敏感性明显增加(P<0.01),在吉西他滨作用下凋亡细胞增多(P<0.01)。结论通过si RNA抑制THOC1的表达后可以增加胰腺癌Panc-1细胞对吉西他滨的药物敏感性。 [ObjectIve] To investigate the effects of silencing THOC1 by siRNA on the sensitivity of pancreas cancer cells Panc-I to gemcitabine. [ Methods ] The THOC1 siRNA (THOC1 siRNA) or Control siRNAamble siRNA (Control siRNA) were transient transfected into Panc-1 cells. The mRNA and protein levels of THOC1 were detected by qPCR and Western blot in the Panc-lcells of different groups. In vitro gemcitabine sensitivity of THOC1 siRNA and Control siRNA transfected Panc-lcell lines was tested by MTF assay and colony formation assay. Hoechst 33258 nuclear staining were used to investigate the effect of silencing THOC1 on the sensitivity of Control siRNA, THOCI siRNA transfected Panc-lcells and nontreated counterparts undergemcitabine induced apoptosis. [Results ] The transient transfection cell lines were successfully established. Both protein and mRNA levels of THOC1 were ef- fectively down-regulated in the THOC1 siRNA transfected Panc-lcells. Down-regulation of THOC1 significantly en- hanced the sensitivity of Panc-lcells in response to gemcitabine(P 〈0.01). In addition, the THOC1 siRNA transfect- ed Panc-1 cells displayed significant apoptosis as assessed by Hoechst nuclear staining (P 〈0.01). [ Conclusions] Silencing THOC1 by siRNA could enhance the sensitivity of pancreas cancer cells Panc-1 to gemcitabine.
作者 曾韦 何剪太
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第36期23-26,共4页 China Journal of Modern Medicine
关键词 THOC1 si RNA 胰腺癌 吉西他滨 化疗敏感性 THOC1 siRNA pancreas cancer gemcitabine chemosensitivity
  • 相关文献

参考文献11

  • 1HIDALGO M. Pancrealie cancer[J]. New England Journal of Medifine, 2010, 362(17): 1605-1617.
  • 2BURRIS HA 3RD, MOORE MJ, ANDERSEN J, et M. Improvements in survival and clinical benefit with gemcitabine as first-fine therapy for palienls with advanced pancreas cancer: a randomized trial[JI. J Clin Oncol, 1997, 15(6): 2403-2413.
  • 3SAKURABA S, TOYOK1 Y, ISHIDO K, el al. Study of unresectable pancreatic cancer-successful resections 'afler gemcilaline-]3a.,sed chemotherapy[J]. Gan To Kagaku Ryoho, 2013, 40(12): 1878-I880.
  • 4GASPARRI F, SOLA F, LOCATELLI G, et zl. The death domain pro- lein p84N5, but not the short isofonn pg4N5s, is cell (:ycle-regalale(I and shullles between Ihe nucleus and the cytoplasm[J]. FEBS Lell, 2004, 574(1-3): 13-19.
  • 5CAO H, LE D, YANC LX. Curren| stalus in henmlherapy for advan:ed panerealie adenoereinoma[J]. Antieaneer les, 2013, 33(5): 1785-1791.
  • 6I MANCINI AI, NIEMANN-SEYDE SC, PANKOW R, el al. THOC5/ FMIP, an mRNA export TREX complex prolcin, is essential for hemltopoicfic primitive cell survival in vivo[J]. BMC Biol, 2010, 8: t.
  • 7GARNER E, MARTINON F, TSCHOPP .l, at al. ells wilh detclive p53-p21-pRh pathway are susceptible to apoplosis induced by p84N5 via caspase-6[J]. Cancer Res, 2007, 67(1 6): 7631-7637.
  • 8WAN J, ZOU S, HU M, el al.Thoc l inhibits cell growth via induclion of cell cycle arresl and apoptosis in lung cancer cells[J]. Mol Med Rep, 2014, 9(6): 2321-2327.
  • 9LIN YS, LIN CH0 HUANG LD, et al. The suppre.qsion of lho I in can- cer cell apoptosis mediated by activated macrophages is nitric ox- ide-dependent[J]. Biochern Pharmacol, 2013, 86(2): 242-252.
  • 10PITZONKA L, ULLAS S, CHINNAM M, et al. The Thocl encoded ri- |wnueleoprotein is required hr myeloid progenitor" cell homestasis in the adult mouse[J]. PLoS One, 2014, 9(5): e9762g.

同被引文献19

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部